C3 and Alzheimer disease: APOE ε4 genotype had no effect on plasma levels of complement proteins implicated in AD (C1q, C3, C9, clusterin) or any of the proteins measured; however, the number of APOE ε4 carriers in the sample sets was low (n = 16).